Literature DB >> 3546650

Contribution of extrahepatic tissues to biochemical abnormalities in hereditary tyrosinemia type I: study of three patients after liver transplantation.

M Tuchman, D K Freese, H L Sharp, M L Ramnaraine, N Ascher, J R Bloomer.   

Abstract

Three patients with hereditary tyrosinemia type I were examined before and after liver transplantation to assess the role of extrahepatic tissues in the biochemical disorders of this disease. Before transplantation the three patients excreted excessive amounts of succinylacetoacetate (SAA), succinylacetone (SA), tyrosyl acidic compounds, and 5-aminolevulinate (ALA). The activity of 5-aminolevulinate dehydratase (ALA-D) in red blood cells was markedly inhibited (1% to 5% of control) in the three patients. Successful liver transplantation resulted in decreased excretion of urinary SAA plus SA, tyrosyl acidic compounds, and ALA. Two of the patients continued to excrete significant amounts of SAA plus SA, whereas those compounds were undetectable in the urine of the third patient. Tyrosine loading resulted in increased excretion of SAA plus SA in two patients, but those compounds remained undetectable in the third. All three patients continued to excrete higher than normal amounts of ALA, but the activity of ALA-D in red blood cells returned to normal after transplantation, indicating marked clearance of SA from the blood. Liver transplantation may not totally correct the biochemical abnormalities of hereditary tyrosinemia. It is likely that the kidney is the source of persistent biochemical aberrations in the urine without significant effects on the blood. Our results suggest the existence of heterogeneity for renal involvement in hereditary tyrosinemia.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3546650     DOI: 10.1016/s0022-3476(87)80501-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  12 in total

1.  Renal function in tyrosinaemia type I after liver transplantation: a long-term follow-up.

Authors:  L J W M Pierik; F J van Spronsen; C M A Bijleveld; C M L van Dael
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

2.  Liver transplantation for hereditary tyrosinemia: the Quebec experience.

Authors:  K Paradis; A Weber; E G Seidman; J Larochelle; L Garel; C Lenaerts; C C Roy
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

3.  Treatment of two children with hereditary tyrosinaemia type I and long-standing renal disease with a 4-hydroxyphenylpyruvate dioxygenase inhibitor (NTBC).

Authors:  E Pronicka; E Rowinska; Z Bentkowski; J Zawadzki; E Holme; S Lindstedt
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

4.  Liver transplantation in nine Spanish patients with tyrosinaemia type I.

Authors:  C Pérez-Cerdá; B Merinero; P Sanz; M Castro; J Gangoiti; M J García; M Díaz; E Medina; M Ugarte
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

5.  Liver transplantation for tyrosinemia. A review of 10 cases from the University of Pittsburgh.

Authors:  L A Mieles; C O Esquivel; D H Van Thiel; B Koneru; L Makowka; A G Tzakis; T E Starzl
Journal:  Dig Dis Sci       Date:  1990-01       Impact factor: 3.199

Review 6.  Current strategies for the treatment of hereditary tyrosinemia type I.

Authors:  Merja Ashorn; Sari Pitkänen; Matti K Salo; Markku Heikinheimo
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

7.  Early nitisinone treatment reduces the need for liver transplantation in children with tyrosinaemia type 1 and improves post-transplant renal function.

Authors:  David C Bartlett; Carla Lloyd; Patrick J McKiernan; Phil N Newsome
Journal:  J Inherit Metab Dis       Date:  2014-02-11       Impact factor: 4.982

8.  Visceral pathology of hereditary tyrosinemia type I.

Authors:  P Russo; S O'Regan
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

Review 9.  Tyrosinaemia type I--an update.

Authors:  E A Kvittingen
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

Review 10.  Treatment of inherited metabolic disorders by liver transplantation.

Authors:  M Burdelski; B Rodeck; A Latta; K Latta; J Brodehl; B Ringe; R Pichlmayr
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.